Search is Powered by Google
Cancer / Oncology News

Killing Two Birds With One Stone

Main Category: Cancer / Oncology
Article Date: 14 Sep 2008 - 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:2 stars

2 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

A formula has been developed to assign utility values to quality of life profiles described by the English and Chinese versions of the Functional Assessment of Cancer Therapy-General (FACT-G), which is a commonly used questionnaire in cancer care and research.

While there are many useful questionnaires to describe a cancer patient's quality of life, most of them do not quantify the health utility value of that quality of life situation, a requirement for cost-utility analysis.

A recent study of English and Chinese speaking cancer patients in Singapore, a multi-ethnic modern society in Asia, used two types of well-established questionnaires to assess the quality of life and health utility of the participants. Statistical methods are then used to develop a formula for assigning a health utility value based on the FACT-G description.

The study report will be appearing in Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research.

Lead author Dr. Yin Bun Cheung says "Our study offers an equation for calculating a health utility index at the group level based on the English or Chinese versions of the Functional Assessment of Cancer Therapy - General. This can facilitate cost-utility and other pharmacoeconomic studies without imposing additional assessment burden on patients."

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research and help health care leaders to make decisions that are solidly evidence-based. The journal is published bi-monthly and has a regular readership of over 3,000 clinicians, decision-makers, and researchers worldwide.

ISPOR is a nonprofit, international organization that strives to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce health care resources wisely, fairly, and efficiently.

ABSTRACT

http://www.ispor.org




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...